Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care

Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care

Current biopharmaceutical manufacturing systems are not compatible with portable or distributed production of biologics, as they typically require the development of single biologic-producing cell lines followed by their cultivation at very large scales. Therefore, it remains challenging to treat pa...

Full description

Bibliographic Details
Main Authors: Cleto, Sara (Contributor), Lee, Kevin (Author), Perez-Pinera, Pablo (Contributor), Han, Ningren (Contributor), Cao, Jicong (Contributor), Purcell, Oliver (Contributor), Shah, Kartik A (Contributor), Ram, Rajeev J (Contributor), Lu, Timothy K (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor), Massachusetts Institute of Technology. Research Laboratory of Electronics (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Nature Publishing Group, 2017-05-15T13:51:01Z.
Subjects:
Article
Online Access:Get fulltext

Similar Items

Similar Items